ARTICLE | Clinical News
DMI begins Ciprofloxacin GR study
October 1, 2001 7:00 AM UTC
DepoMed (DMI) began a Phase II study comparing its Ciprofloxacin GR extended-release formulation to the marketed immediate-release formulation, Cipro ciprofloxacin from Bayer (FSE:BAYG). The double-bl...